Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Hazem AbuEl-Enien"'
Autor:
Mohamed Sayed Zaazouee, Rokaya Y. Ebrahim, Ghaida’a Al-araj, Ibram Zaki, Ahmed Saad, Abdullah Mohamed Farhat, Mustafa Hussein Ali, Mohamed Elshennawy, Omar Khaled Fahmy Fawy, Hadi F. Ahmed, Ziad Alahmad, Eman Ayman Nada, Reem I. Abo-Hamra, Ahmed Bostamy Elsnhory, Mohammed Eleyan, Hazem AbuEl-Enien, Rasha Abdo Elromely, Yossef Hassan AbdelQadir, Jaffer Shah, Alaa Ahmed Elshanbary
Publikováno v:
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-15 (2024)
Abstract Background The humanized monoclonal antibody galcanezumab is an anti-calcitonin-gene-related-peptide (CGRP) and frequently used for migraine prevention. However, the literature revealed limited data with conflicting results. This study aims
Externí odkaz:
https://doaj.org/article/6bfd72377cf642e7a03b4d230493d28f
Autor:
Mohamed Sayed Zaazouee, Asmaa Gomaa Alwarraqi, Yasmine Adel Mohammed, Mohamed A. Badheeb, Abdullah Mohamed Farhat, Mohammed Eleyan, Afnan Morad, Marwa Abdel-Aziz Zeid, Aya Shaban Mohamed, Hazem AbuEl-Enien, Ahmed Abdelalim, Ahmed Bostamy Elsnhory, Yasmin S. M. Hrizat, Nagat Taha Altahir, Doaa Atef, Alaa Ahmed Elshanbary, Khalaf F. Alsharif, Khalid J. Alzahrani, Mohammad Algahtani, Abdulrahman Theyab, Yousef M. Hawsawi, Ahmed A. Aldarmahi, Mohamed M. Abdel-Daim
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Dupilumab is a human monoclonal antibody directed against the alpha subunit of the interleukin-4 receptor and inhibits the signaling of IL-4 and IL-13. It is approved for treating asthma and other type-2 inflammatory diseases. There is a
Externí odkaz:
https://doaj.org/article/3544b8575c1c4d958220176a876ad7f3
Autor:
Mohamed Sayed Zaazouee, Ahmed Elsnhory, Rokaya Y. Ebrahim, Ghaida’a Al-araj, Ahmed Saad, Ibram Zaki, Mustafa Hussein Ali, Omar Khaled Fahmy Fawy, Hadi F. Ahmed, Mohamed Elshennawy, Mohammed Eleyan, Ziad Alahmad, Reem I. Abo Hamra, Hazem AbuEl-Enien, Rasha Abdo Elromely, Alaa Ahmed Elshanbary
Publikováno v:
Wednesday, April 26.